Healthcare provider profile · identity verified

Prity Rawal, MD

Family Practice · GENESEO, NY · NPI 1851650998

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	290	82
Lisinopril	Lisinopril	238	57
Levothyroxine Sodium	Levothyroxine Sodium	222	60
Amlodipine Besylate	Amlodipine Besylate	188	54
Omeprazole	Omeprazole	188	52
Gabapentin	Gabapentin	170	37
Albuterol Sulfate Hfa	Albuterol Sulfate	164	75
Rosuvastatin Calcium	Rosuvastatin Calcium	144	40
Prednisone	Prednisone	125	93
Metoprolol Succinate	Metoprolol Succinate	104	26
Ozempic	Semaglutide	103	16
Alprazolam	Alprazolam	88	19
Azithromycin	Azithromycin	87	75
Hydrochlorothiazide	Hydrochlorothiazide	83	24
Montelukast Sodium	Montelukast Sodium	79	20
Pantoprazole Sodium	Pantoprazole Sodium	79	23
Losartan Potassium	Losartan Potassium	78	27
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	75	24
Simvastatin	Simvastatin	74	22
Metformin Hcl	Metformin Hcl	71	18
Trazodone Hcl	Trazodone Hcl	69	17
Amoxicillin	Amoxicillin	66	54
Metformin Hcl Er	Metformin Hcl	65	18
Sertraline Hcl	Sertraline Hcl	62	23
Zolpidem Tartrate	Zolpidem Tartrate	60	suppressed
Oxycodone Hcl	Oxycodone Hcl	57	13
Pravastatin Sodium	Pravastatin Sodium	56	18
Tamsulosin Hcl	Tamsulosin Hcl	56	16
Duloxetine Hcl	Duloxetine Hcl	55	15
Hydroxyzine Hcl	Hydroxyzine Hcl	55	16
Meloxicam	Meloxicam	55	16
Furosemide	Furosemide	53	15
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	52	41
Famotidine	Famotidine	52	16
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	52	27
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	48	23
Bupropion Xl	Bupropion Hcl	47	14
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	46	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	46	11
Symbicort	Budesonide/Formoterol Fumarate	46	suppressed
Cephalexin	Cephalexin	45	40
Doxycycline Hyclate	Doxycycline Hyclate	43	32
Eliquis	Apixaban	43	suppressed
Atenolol	Atenolol	41	11
Escitalopram Oxalate	Escitalopram Oxalate	40	12
Citalopram Hbr	Citalopram Hydrobromide	39	11
Breo Ellipta	Fluticasone/Vilanterol	37	suppressed
Spironolactone	Spironolactone	37	suppressed
Tramadol Hcl	Tramadol Hcl	32	13
Glipizide Er	Glipizide	31	suppressed
Tizanidine Hcl	Tizanidine Hcl	31	suppressed
Fluticasone Propionate	Fluticasone Propionate	30	13
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	30	14
Irbesartan	Irbesartan	29	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	28	suppressed
Celecoxib	Celecoxib	27	suppressed
Methylprednisolone	Methylprednisolone	27	22
Ondansetron Odt	Ondansetron	27	15
Valacyclovir	Valacyclovir Hcl	27	12
Mirtazapine	Mirtazapine	26	suppressed
Ezetimibe	Ezetimibe	25	suppressed
Paroxetine Hcl	Paroxetine Hcl	25	suppressed
Fluconazole	Fluconazole	24	19
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	24	suppressed
Np Thyroid	Thyroid,pork	24	suppressed
Diclofenac Sodium	Diclofenac Sodium	21	14
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	21	20
Xarelto	Rivaroxaban	21	suppressed
Bupropion Hcl Sr	Bupropion Hcl	20	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	20	suppressed
Lorazepam	Lorazepam	20	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	20	14
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	19	suppressed
Mometasone Furoate	Mometasone Furoate	19	suppressed
Potassium Chloride	Potassium Chloride	19	suppressed
Spiriva Respimat	Tiotropium Bromide	19	suppressed
Carvedilol	Carvedilol	18	suppressed
Clopidogrel	Clopidogrel Bisulfate	18	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	18	suppressed
Ibuprofen	Ibuprofen	18	suppressed
Naloxone Hcl	Naloxone Hcl	18	17
Fluoxetine Hcl	Fluoxetine Hcl	17	suppressed
Jardiance	Empagliflozin	17	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	17	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	17	16
Venlafaxine Hcl Er	Venlafaxine Hcl	17	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	16	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Nystatin	Nystatin	16	suppressed
Propranolol Hcl	Propranolol Hcl	16	suppressed
Ramipril	Ramipril	16	suppressed
Warfarin Sodium	Warfarin Sodium	16	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	15	suppressed
Trulicity	Dulaglutide	15	suppressed
Clonazepam	Clonazepam	14	suppressed
Finasteride	Finasteride	14	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	14	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	14	suppressed
Boostrix Tdap	Diphth,pertuss(Acell),tet Vac	13	13
Esomeprazole Magnesium	Esomeprazole Magnesium	13	suppressed
Metronidazole	Metronidazole	13	suppressed
Synthroid	Levothyroxine Sodium	13	suppressed
Baclofen	Baclofen	12	suppressed
Buprenorphine	Buprenorphine	12	suppressed
Desloratadine	Desloratadine	12	suppressed
Diazepam	Diazepam	12	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	12	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	12	suppressed
Gemfibrozil	Gemfibrozil	12	suppressed
Glimepiride	Glimepiride	12	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	12	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	11	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	11	11
Oxybutynin Chloride Er	Oxybutynin Chloride	11	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	11	suppressed
Torsemide	Torsemide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error